Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Dexmedetomidine (0.0055%) on Intraocular Pressure in Healthy Eyes
NCT03690622Phase 4Completed
- Sponsor
- Beirut Eye Specialist Hospital
- Start
- Dec 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine in Glaucoma, ocular hypertension, sponsored by Beirut Eye Specialist Hospital. Started Dec 2017; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT03690622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03690622.